Furthermore, chronic IL-6 exposure in cancer patients may induce not only wasting in skeletal muscles due to increased protein breakdown and decreased induction of post-prandial muscle protein synthesis [37], but also tumorigenesis [38]. Here, IL6 is linked to cancer.